EyeCool Therapeutics Announces Results of Pilot Study of Novel Chronic Ocular Surface Pain Treatment
Clinical-stage medical technology company EyeCool Therapeutics, based in Cambridge, Massachusetts, has announced positive results from a pilot study on its investigational ETX-4143 device for the treatment of chronic ocular surface pain (COSP).
- 1404/6/15
- more...